The United States of America › United States House of Representatives

H.R. 3082

Evidence-Based Drug Policy Act of 2025

Session

Status

Pending

Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors (2)

Dina Titus

Democrat · Primary

Ilhan Omar

Democrat · Primary

Legislative Votes

No votes have been held on this legislation yet.